Dare Bioscience Inc (DARE) — Cash Flow-to-Debt Ratio
Dare Bioscience Inc (DARE) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of $1.44 Million could theoretically repay 0% of its total liabilities ($29.63 Million) in one year. See DARE FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dare Bioscience Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Dare Bioscience Inc across 15 annual periods. Also explore net asset growth rate of Dare Bioscience Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Dare Bioscience Inc (2011–2025)
Year-by-year debt coverage analysis for Dare Bioscience Inc. For market capitalisation and broader financial context, see how much is Dare Bioscience Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -333.62x | $-9.89 Billion | $29.63 Million | ▼ -173974.0% |
| 2024 | 0.19x | $5.39 Million | $28.11 Million | ▲ +113.0% |
| 2023 | -1.48x | $-38.86 Million | $26.33 Million | ▼ -166.9% |
| 2022 | -0.55x | $-18.09 Million | $32.71 Million | ▲ +67.2% |
| 2021 | -1.69x | $-28.76 Million | $17.05 Million | ▲ +41.8% |
| 2020 | -2.90x | $-25.23 Million | $8.70 Million | ▼ -52.5% |
| 2019 | -1.90x | $-13.32 Million | $7.00 Million | ▲ +79.6% |
| 2018 | -9.33x | $-10.27 Million | $1.10 Million | ▼ -255.1% |
| 2017 | -2.63x | $-2.54 Million | $967.04K | ▼ -92.5% |
| 2016 | -1.36x | $-33.54 Million | $24.58 Million | ▼ -26.1% |
| 2015 | -1.08x | $-31.91 Million | $29.48 Million | ▲ +54.2% |
| 2014 | -2.36x | $-19.06 Million | $8.07 Million | ▼ -36.7% |
| 2013 | -1.73x | $-16.61 Million | $9.62 Million | ▼ -703.7% |
| 2012 | -0.21x | $-21.00 Million | $97.70 Million | ▲ +94.5% |
| 2011 | -3.89x | $-16.88 Million | $4.34 Million | — |